The New York Times this morning posted an article on the financial cost of small advances in diabetes treatment.
One of the most bothersome quotes to me is:
Drugs and equipment makers operate in a global market, and our costs are higher because every other country applies price controls, and we don’t. -Robert J. Shapiro, an economist and chairman of Sonecom L.L.C., a Washington-based financial advisory firm.
What do you think about the way things are heading? Leave a comment with your ideas.